The Hyderabad University (UOH) has signed an agreement with Krismo Cinemoscience Limited to develop therapies for inflammatory diseases and serious infectious conditions.
“To Key Focus Will Be on the Design of Antibody-Based Therapies to Effective Viral Infections, Including Dengue, Covid-19 and influenza, as well as potent toxins produced by Harmful Bacteria Response,” Profitating, “Profating,” Profitating, “Profitating,” Profitating Like of Like of Like of Like of Like Like of Like of, “Like Gangren,” Like’s Like of, “Like Gangren,” Like’s Like’s Like’s Like Life Sciences of UOH, said here in a statement on Saturday.
Posted on May 3, 2025
